Year: 2016
Type: article
Abstract: Acetylcholine (ACh) is one of the main neuromodulators in the mammalian central nervous system (CNS). This chemical messenger has been implicated in the underlying physiology of many distinct cognitive functions. However, the exact role that ACh plays in regulating information processing in the brain is still not fully understood. The vesicular acetylcholine transporter (VAChT) is required for the storage of ACh into synaptic vesicles, and therefore it presents a means to modulate release. Diminished VAChT levels cause a decrease in cholinergic tone, whereas increased VAChT expression has been shown to augment ACh release. Previously published data have shown that elimination of VAChT in the basal forebrain in genetically-modified mice impairs learning and memory.\nFor our studies we have used different mouse lines in which the expression of the VAChT gene is changed, both increased and decreased. We are therefore able to study the consequences of altered cholinergic tone in vivo. Our hypothesis is that changes in cholinergic tone produce specific molecular signatures in target brain areas that underlie alterations in cognitive function. Our studies aimed to elucidate the behavioural and molecular consequences of cholinergic dysfunction. Behavioral testing included classical learning and memory tests as well as sophisticated tasks using novel touch screens chambers to measure attention, learning and memory as well as cognitive flexibility. At the molecular level, the goal was to examine how long-term changes in cholinergic tone impact mechanisms regulating synaptic plasticity and neuronal health. Finally, by aging mouse models of cholinergic dysfunction we were able to elucidate the role that cholinergic tone plays in the classical pathological hallmarks of neurodegenerative disorders.\nUltimately, by establishing the molecular signature of increased and decreased cholinergic tone in targeted brain regions (cortex and hippocampus) it may become possible to find novel targets for therapeutic interventions to improve cognitive deficits due to altered cholinergic tone.
Author: Benjamin Kolisnyk
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Funders: Heart and Stroke Foundation of Canada, Teva Pharmaceutical Industries, Yeshiva University, Fondation Brain Canada, Weston Brain Institute, Alzheimer's Society, European Commission, Fundação de Amparo à Pesquisa do Estado de São Paulo, Hebrew University of Jerusalem, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Israel Science Foundation, Kuwait University, Hospital for Sick Children, Albert Einstein College of Medicine, Yeshiva University, Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Ciência sem Fronteiras, FP7 People: Marie-Curie Actions
Awards: G1198167406, Physiological functions of the cellular prion protein, G1708994582, G225687179, G2557024270, G3324273848, G3852940975, G5020230825, G5350679257, G5518805754, G5690064113, Mechanisms associated with the function of prion protein and its ligand STI1/Hop: therapeutic approaches, G7225318720, G7868512380, G8862700276
OpenAlex ID: W2525867720
